The incretin hormones glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) regulate glucose homeostasis and are recognized as important therapeutic targets for diabetes and obesity (15, 16). This evidence concerns the gene GIP and obesity due to melanocortin 4 receptor deficiency.